Haem/Onc Flashcards

1
Q

Drugs in haem-onc?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chemotherapy extravasation points?

A
  • Usually cold compress except vinca alkaloids –> heat compress
  • Doxorubacin and daunorubicin extravasation tends to cause ulceration –> plastics referral, topical steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

General points with transfusion reactions?

A
  • Bacterial contamination very rare with red cell transfusions, more common with platelet transfusions which are stored at room temp
  • IgG antibodies cause delayed extravascular haemolytic reactions much more commonly than acute intravascular reactions
  • IgM anti-A and anti-B antibodies cause acute haemolytic transfusion reactions
  • Anti-O doesn’t exist
  • ABO antigens present from birth, ABO antibodies acquired in first 6 months of life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Delayed transfusion reactions?

A

Occurs 5-10 days post-transfusion due to development of red cell alloantibodies

  • Unexplained pyrexia, jaundice or unexplained drop in heamoglobin
  • Urinalysis shows urobilinogenuria and a blood shows fragile ballooned spherocytes
  • Diagnosis is confirmed by Coombs test which is done by adding antihuman globulin (AHG) (anti-Ig G and anticomplement) to the patient’s washed RBCs. A positive test results in red cell agglutination.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Intravascular vs Extravascular Haemolysis?

A

Intravascular

  • Mismatched blood transfusion
  • G6PD deficiency
  • Red cell fragmentation: heart valves, TTP, DIC, HUS
  • Paroxysmal nocturnal hemoglobinuria
  • Cold autoimmune hemolytic anemia

Extravascular (usually abnormal RBC shape/RBC membrane disorders)

  • Hemoglobinopathies: sickle cell, thalassemia
  • Hereditary spherocytosis
  • Hemolytic disease of newborn
  • Warm autoimmune hemolytic anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Autoimmune Haemolytic Anaemia? (Warm vs Cold)

A

Usually idiopathic but can be secondary to lymphoproliferative disorder, infection or drugs. Characterised by a positive direct antiglobulin test (Direct Coombs’ test)

Cold AIHA

  • IgM
  • Causes haemolysis at 4oC - mediated by complement and more commonly intravascular
  • Features = Raynaud’s, acrocyanosis
  • Causes = Neoplasia (e.g. Lymphoma), Infections (e.g. Mycoplasma, EBV

Warm AIHA

  • IgG
  • Casues haemolysis at body temperature - haemolysis occurs at extravascular sites (i.e. spleen)
  • Management = steroids, immunosuppression, splenectomy
  • Causes = Autoimmune disease (SLE), Neoplasia (Lymphoma, CLL), Drugs (Methyldopa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Difference between direct and indirect Coomb’s test?

A

Direct - detects antibodies or complement proteins that are bound to RBCs. Serum incubated with antihuman globulin –> if agglutination of RBCs then test is +ve.

Indirect - detects antiboides against RBCs that are unbound in the serum. Serum extracted and incubated with donor RBCs of known antigenicity. Antihuman globulin added –> if agglutination of RBCs then test is +ve

Indirect used in prenatal screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hereditary spherocytosis?

A
  • Most common hereditary hemolytic anemia in northern Europeans
  • Autosomal Dominant defect of RBC cytoskeleton –> sphere shape instead of biconcave disc
  • Reduced RBC survival, destroyed by the spleen

Presentation

  • Chronic haemolysis and gallstone formation
  • Failure to thrive
  • Jaundice
  • Splenomegaly
  • Aplastic crisis preipitated by parvovirus infection
  • MCV reduced, MCHC increased, Reticulocytes increased

Diagnosis

  • Osmotic fragility test (spherocytes rupture in mildly hypotonic solution)

Mx

  • Folate replacement
  • Splenectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathophysiology of sickle cell disease?

A
  • Autosomal recessive
  • Mutation in b-globin chain of Hb (chromosome 11) - glutamic acid replaced with valine at 6th position
  • Two normal a-globin subunits with two mutant b-globin subunits –> HbS

Types

  • Homozygotes - HbSS (sickle cell anaemia)
  • Heterozygotes - 1 sickle gene and 1 normal gene –> HbAS (sickle cell trait)
  • Rarer forms - compound heterozygous states where person has only one copy of HbS mutation and one copy of another abnormal Hb allele
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of sickle cell crisis?

A
  1. Thrombotic (painful)
    • Vaso-occlusive
    • Precipitated by infection, dehydration, deoxygenation
    • Infarcts occur in various organs including the bones (e.g. avascular necrosis of hip), hand-foot syndrome in children, lungs, spleen and brain
  2. Aplastic
    • Caused by infection with parvovirus
    • Sudden fall in hemoglobin
  3. Sequestration (spleen, liver and kidney)
    • Sickling within organs such as the spleen or lungs causes pooling of blood with worsening of the anaemia
    • Acute chest syndrome: dyspnea, chest pain, pulmonary infiltrates, low PO2 - the most common cause of death in adults (Hydroxyurea –> the incidence of acute chest syndrome)
    • The most common cause of death in childhood: infraction and infection (Pneumococcus, Chlamydia, Mycoplasma)
  4. Haemolytic
    • Rare - fall in Hb due to increased rate of haemolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pernicious anaemia?

A
  • Investigation
    • Anti-gastric parietal cell antibodies in 90% (low specificity)
    • Anti-intrinsic factor antibodies in 50% (specific for pernicious anaemia)
  • Macrocytic anaemia, low WBC and platelets
  • LDH may be raised due to ineffective erythropoiesis
  • Hypersegmented polymorphs on film, megaloblasts in marrow
  • Schilling test
    • Radiolabelled B12 given on two occasions
    • First on its own, second with oral Intrinsic Factor
    • Urine B12 levels measured
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sideroblastic anaemia?

A

Condition where red cells fail to completely form heme, whose biosynthesis takes place partly in the mitochondrion. This leads to deposits of iron in the mitochondria
that form a ring around the nucleus called a ring sideroblast. It may be congenital or acquired.

Causes

  • Congenital = Delta-aminolevulinate synthase-2 deficiency
  • Acquires = myelodysplasia, alcohol, lead, Chloramphenicol and Anti-TB medications (INH + Pyrazinamide)

Investigations

  • Hypochromic microcytic anemia (more so in congenital)
  • Bone marrow: sideroblasts and increased iron stores

Mx

  • Supportive, treat underlying cause
  • Pyridoxine may help
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pure red cell aplasia?

A

Unexplained anaemia and reticulocytopenia, with a complete absence of red cell precursors in the bone marrow, but with preservation of other cell lines.

Associations

  • Spontaneous
  • Thymoma
  • Autoimmune
  • Lymphoproliferative disorders
  • Can rarely occur where recombinant erythropoietin is administered, where antierythropoietin antibodies can be detected

Treatment

  • Supportive with immunosuppression with ciclosporin or related compounds
  • Withdrawal of erythropoietin –> subsequent falling of antibody levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Glucose-6-phosphate dhydrogenase (G6PD) deficiency?

A
  • Commonest red cell enzyme defect - more common in people from the med/africa
  • Pathway involves NADPH/reduced glutathione which usually protect RBCs from oxidative phosphorylation
  • X-linked recessive inheritence
  • Drugs can precipitated a crisis (as can Fava beans)

Features

  • Neonatal jaundice is often seen
  • Intravascular hemolysis
  • Heinz bodies on blood films (indicates oxidative damage to the Hb)

Drugs causing haemolysis

  • Anti-malarials: primaquine
  • Ciprofloxacin
  • Sulfonamides
  • Co-trimoxazole (because it contains sulfa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Paroxysmal noctural haemoblobinuria (PNH)?

A
  • Acquired disorder leaidng to haemolysis (intravascular)
  • Caused by increased sensitivity of cell membranes to complement due to a lack of glycoprotein glycosyl-phosphatidylinositol (GPI)
  • Also prone to venous thrombosis
    • GPI = anchor which attaches surface proteins to cell membrane
    • Complement-regulating surface proteins, e.g. decay-accelerating factor (DAF), are not properly bound to the cell membrane due a lack of GPI
    • Thrombosis is thought to be caused by a lack of CD59 on platelet membranes predisposing to
      platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Features, diagnosis and Mx of PNH?

A

Features

  • Hemolytic anemia
  • Red blood cells, white blood cells, platelets or stem cells may be affected therefore pancytopenia may be present
  • Haemoglobinuria: classically dark-colored urine in the morning
  • Thrombosis e.g. Budd-Chiari syndrome
  • Aplastic anemia may develop in some patients

Diagnosis

  • Flow cytometry of blood to detect low levels of CD59 and CD55
  • Ham’s test was previously gold standard - acid-induced hemolysis (normal red cells would not)

Mx

  • Blood product replacement
  • Anticoagulation
  • Eculizumab, a monoclonal antibody directed against terminal protein C5
  • Stem cell transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Causes of polycythaemia?

A

Relative

  • Dehydration
  • Stress: Gaisbock syndrome

Primary

  • Polycythaemia Rubra Vera

Secondary

  • COPD
  • Altitude
  • OSA
  • Excessive erythropoietin: cerebellar hemangioma, hypernephroma, hepatoma, uterine fibroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How to differentiate between true (pimary or secondary) polycythaemia and relative polycythaemia?

A

Red Cell Mass Studies

  • In true polycythaemia
    • males > 35 ml/kg
    • women > 32 ml/kg

Erythroid colony studies

  • Autonomous growth of erythroid colonies is taken as a sign of primary
    polycythaemia, where erythropoiesis has escaped the control of erythropoietin
  • Arythroid colony studies are thought to have high specificity for detecting primary versus secondary polycythaemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Polycythaemia Rubra Vera?

A
  • Myeloproliferative disorder caused by clonal proliferation of a marrow stem cell leading to raised RBCs, often accompanied by raised WBC (neutrophils) and raised platelets.
  • JAK2 +ve in 95%
  • 50-60 yrs
  • Association with Budd-Chiari syndrome
  • About 30% progress to myelofibrosis; 5-15% develop an acute leukaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Features, investigation and management of PRV?

A

Features

  • Hyperviscosity (headaches, tinnitus, visual disturbance, cyanosis, joint pain)
  • Pruritus, typically after a hot bath
  • Splenomegaly ± Hepatomegaly
  • Thrombotic events
  • Hemorrhage (secondary to abnormal platelet function not number)
  • Plethoric appearance
  • Low ESR
  • Hypertension in a third of patients

Investigations

  • Raised Hemoglobin and hematocrit
  • Raised Leucocyte alkaline phosphatase (LAP)
  • ± raised WBC and raised PLT
  • ± raised Plasma volume
  • Raised vitamin B12
  • Raised Red cell mass
  • Reduced Erythropoietin level

Mx

  • Venesection - first line treatment
  • Hydroxyurea -slight increased risk of secondary leukemia
  • Allopurinol & Phosphorus-32 therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Causes of neutropenia? Investigations?

A

Congenital

  • Kostmann’s syndrome
  • Chediak–Higashi
  • Schwachmann–Diamond syndrome
  • Cyclical neutropenia

Acquired

  • Infection: viral e.g. influenza, HIV, hepatitis, bacterial sepsis.
  • Drugs: anticonvulsants (phenytoin) – anti-thyroid (carbimazole) – phenothiazines (chlorpromazine) – antibacterial agents (cotrimoxazole) – ACE-inhibitors (ramipril)
  • Immune-mediated: SLE, Felty’s syndrome (Rheumatoid Arthritis + Neutropenia + Splenomegaly)
  • Bone marrow failure: leukaemia, lymphoma, Hematinic deficiency
  • Splenomegaly: any cause

Investigations

  • Blood film
  • Hematinics: factors that increase Hb (Iron, TIBC, Vit B12, Folic Acid, Vit D)
  • Autoimmune profile bone marrow aspirate/trephine are indicated if there are severe or prolonged neutropenia or features suggestive of marrow failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Leukemoid reaction?

A
  • Presence of immature cells such as myeloblasts, promyelocytes and nucleated red cells in the peripheral blood
  • May be due to infiltration of the bone marrow causing the immature cells to be ‘pushed out’ or sudden demand for new cells

Causes

  • Severe infection
  • Severe hemolysis
  • Massive hemorrhage
  • Metastatic cancer with bone marrow infiltration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Leukemoid reaction vs CML?

A

Leukemoid Reaction

  • High leukocyte alkaline phosphatase score
  • Toxic granulation (Dohle bodies) in the white cells
  • ‘Left shift’ of neutrophils i.e. increased neutrophils or 3 segments of the nucleus

CML

  • Low leukocyte alkaline phosphatase score
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Myelofibrosis?

A
  • Myeloproliferative disorder caused by hyperplasia of abnormal megakaryocytes responsible for the production of platelets
  • Resultant release of platelet derived growth factor is thought to stimulate fibroblasts
  • Hematopoiesis develops in the liver and spleen

Features

  • E.g. Elderly person with symptoms of anemia e.g. Fatigue (the most common presenting symptom)
  • Massive splenomegaly
  • Hypermetabolic symptoms: weight loss, night sweats etc

Ix

  • Anemia
  • High WBC and platelet count early in the disease
  • ‘Tear-drop’ poikilocytes on blood film
  • Unobtainable bone marrow biopsy - ‘dry tap’ therefore trephine biopsy needed
  • High urate and LDH (reflect increased cell turnover)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Myelodysplasia? (not enough cells)

A

30% progress to AML

Presentation

  • Pancytopenia –> anaemia, infection, bleeding

Investigations

  • Serial blood counts –> evidence of increasing bone marrow failure
  • Bone marrow shows increased cellularity

Management

  • < 5% blasts in the bone marrow –> manage conservatively.
  • Raised WBC –> gentle chemotherapy.
  • < 60 years old –> Intensive chemotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Philadelphia chromosome?

A

Philadelphia chromosome

  • translocation between the long arm of chromosome 9 and 22 -
    t(9:22)(q34:q11). This results in part of the ABL proto-oncogene from chromosome 9 being fused with the BCR gene from chromosome 22.
  • The resulting BCR-ABL gene codes for a fusion protein which
    has tyrosine kinase activity in excess of normal
  • Good prognostic sign in CML
  • Poor prognostic sign in AML + ALL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

CML?

A

Presentation

  • Middle-age
  • Anemia, weight loss
  • Splenomegaly may be marked (lethargy, anorexia, abdominal discomfort – 75% palpable spleen)
  • Hepatomegaly and lymphadenopathy are uncommon
  • Spectrum of myeloid cells seen in peripheral blood
  • Reduced neutrophil alkaline phosphatase
  • May undergo blast transformation (AML in 80%, ALL in 20%)

Diagnosis

  • Philadelphia is confirmatory
  • Peripheral blood film: (leukocytosis in all stages of differentiation within the myeloid linage)
  • Basophilia is important diagnostic marker especially when Philadelphia is absent
  • Monocytopenia
  • Bone-marrow hypercellularity with increased myloid-erythroid ratio

Management

  • Hydroxyurea (also used in PRV, painful attacks in sicklers and as antiretroviral in HIV)
  • Interferon- a
  • Imatinib (inhibitor of tyrosine kinase)
  • Allogenic bone marrow transplant (optimum management)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

AML?

A
  • Most common form of acute leukemia in adults
  • May occur as a primary disease or following a secondary transformation of a myeloproliferative disorder (e.g CML, myelofibrosis)
  • > 30% blasts are almost diagnostic of AML

Presentation (pancytopenia)

  • Early signs are vague and non-specific (influenza-like)
  • Persistent or frequent infections (due to low WBC)
  • Bruising and petechiae (due to low PLT)
  • Splenomegaly may occur but typically mild and asymptomatic. Lymph node swelling is rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How to differentiate AML from ALL?

A

Combination of a myeloperoxidase or Sudan black stain and a non-specific esterase (NSE) stain will provide distinction of AML from ALL and in subclassification of AML in most cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Acute promyelocytic leukaemia?

A
  • M3 subtype of AML
  • Presents younger than other types of AML (25 yrs)
  • Classical presentation = rasied WCC, DIC or thrombocytopenia
  • Associated with t(15:17) translocation which causes fusion of the PML and RAR-a genes.
  • Good prognosis
  • Treated with the ATRA in addition to induction chemotherapy.
    • All-trans-retinoic acid - activates the RAR-a gene thus helps the WBCs to differentiate (i.e mature) but it will not eliminate the leukemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Poor prognostic features for AML?

A
  • > 60 years
  • > 20% blasts after first course of chemo
  • Cytogenics: deletions of chromosome 5 or 7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Management of AML?

A

Chemo divided into two phases

  1. Induction
    • All types (except M3) - cytarabine (ara-C) and an anthracycline (such as daunorubicin or idarubicin)
    • Regimen known as 7+3 - ara-C is given as a continuous IVI for 7 days while the anthracycline is given for 3 consecutive days as an IV push
  2. Consolidation
    • Further therapy needed to eliminate non-detectable disease and prevent relapse
    • For good-prognosis leukemias [t(8;21), and t(15;17)], patients will typically undergo an additional 3–5 courses of intensive chemotherapy
    • For patients at high risk of relapse (e.g. those with high-risk cytogenetics, underlying MDS, or therapy-related AML), allogeneic stem cell transplantation is usually recommended
36
Q

CLL?

A

Caused by a monoclonal proliferation of well-differentiated lymphocytes which are almost always B-cells (99%)

Features

  • Often none
  • Constitutional: anorexia, weight loss
  • Bleeding, infections
  • Lymphadenopathy more marked than CML

Complications

  • Hypogammaglobulinemia leading to recurrent infections most common cause of death
  • Warm autoimmune hemolytic anemia in 10-15% of patients
  • Transformation to high-grade lymphoma (Richter’s transformation)

Poor Prognostic Factors

  • Male
  • Age > 70 years
  • Lymphocyte count > 50
  • Prolymphocytes comprising > 10% of blood lymphocytes
  • Lymphocyte doubling time < 12 months
  • Raised LDH
  • CD38 expression positive
37
Q

Investigations and Tx of CLL?

A

Ix

  • Immunophenotyping (flow cytmetry)
    • Immunophenotyping will demonstrate the cells to be B-cells (CD19 positive). CD5 and CD23 are also characteristically positive in CLL
  • Blood film: smear or smudge cells

Mx

  • None early on
  • Chlorambucil to reduce lymphocyte count
  • Fludarabine
    • causes profound lymphopenia –> increases the risk of opportunistic infections significantly,
    • Give co-trimoxazole or to use monthly nebulised pentamidine to prevent PCP pneumonia
38
Q

Indications for treatment in CLL?

A
  • Progressive marrow failure: the development or worsening of anemia and/or thrombocytopenia
  • Massive (>10 cm) or progressive lymphadenopathy
  • Massive (>6 cm) or progressive splenomegaly
  • Progressive lymphocytosis: > 50% raised over 2 months or lymphocyte doubling time < 6 months
  • Systemic symptoms: weight loss > 10% in previous 6 months, fever >38ºc for > 2 weeks, extreme fatigue, night sweats
  • Autoimmune cytopenias e.g. ITP
39
Q

Hairy cell leukaemia?

A

Rare malignant proliferation disorder of B cells lymphocytes

Classified as a sub-type of chronic lymphoid leukemia

Hairy cells = abnormal WBCs with hair-like projections of cytoplasm.

Features

  • Pancytopenia (Monocytopenia is classical)
  • Splenomegaly
  • Skin vasculitis in 1/3 patients
  • ‘Dry tap’ despite bone marrow hypercellularity (also seen in myelofibrrosis)
  • Bone marrow biopsy migh show “fried egg appearance”
  • Tartrate resistant acid phosphotase (TRAP) stain positive

Management

  • Chemotherapy is first-line: cladribine, pentostatin
  • Immunotherapy is second-line: rituximab, interferon-
  • Splenectomy sometimes required
40
Q

ALL?

A

Causes problems by crowding out normal cells in the bone marrow, and metastasising

2 peaks - 2-5 years, and old age

  • t(12:21) = most common translocation –> good prognosis.
  • Philadelphia chromosome t(9:22) –> bad prognosis.
  • t(4:11) is the most common in children under 12 months and portends a poor prognosis.
41
Q

Presentation of ALL?

A

Presentation

  • Generalized weakness and fatigue, anaemia
  • Frequent or unexplained fever and infections
  • Weight loss and/or loss of appetite
  • Excessive and unexplained bruising; Petechiae due to thrombocytopenia
  • Bone pain, arthralgia.
  • Dyspnea due to lung infiltration.
  • Lymphandeopathy, hepatosplenomegaly.
  • Pitting edema in the lower limbs and/or abdomen
42
Q

Dx of ALL?

A
  • Leukocytosis.
  • Blast cells are seen on blood smear in 90% of cases
  • Bone marrow biopsy is conclusive proof of ALL
  • LP to detect CNS involvement.
  • CXR: to look for mediastinal mass (common in ALL)
  • U&E to look for Tumor Lysis Syndrome.
  • Immunophenotyping, establish whether the “blast” cells origin is B or T lymphocytes
  • DNA testing; different mutations reflect prognosis.

Terminal deoxynucleotide transferase (TdT) present in 95% of ALL

43
Q

Good and bad prognostic factors of ALL?

A

Good

  • Common ALL
  • Pre-B phenotype
  • Low initial WBC
  • FAB L1 type

Bad

  • FAB L3 type
  • T or B cell surface markers
  • Philadelphia translocation, t(9;22)
  • Age < 2 years or > 10 years
  • Male Sex.
  • CNS involvement
  • High initial WBC (e.g. > 100 * 109/l)
  • Non-Caucasian
44
Q

Leukoerythroblastic Anemia?

A
  • Left-shifted granulocytic series and nucleated red blood cells) with pancytopaenia
  • Also defined when there are immature cells (e.g myelocytes, and nucleated red blood cells) seen on the peripheral blood film

Associations

  • Increased Bone marrow turnover e.g. in severe hemolytic anemia (in which case the reticulocyte count would be high).
  • Myelofibrosis and Chronic Myeloid Leukaemia (where there would be splenomegaly, and the white cell and platelet count would usually be raised).
  • Bone marrow invasion. Often in bone marrow invasion the invading malignancy will already have been diagnosed previously.
  • Myeloma
  • Polycythaemia Rubra Vera
  • Osteopetrosis
  • Tuberculous infiltration of the bone marrow
  • Sarcoidosis
45
Q

Hodgkin’s lymphoma?

A
  • Malignant proliferation of lymphocytes characterized by the presence of the Reed-Sternberg cell.
  • Bimodal age distributions being most common in the third and seventh decades.
  • Associated with EBV
  • 25% have constitutional symptoms (night sweats, weight loss, fever, pruritus and lethargy)

Diagnosis

  • Hodgkin results in patchy bone marrow infiltration, an isolated bone marrow biopsy may yield non-specific results.
  • Bone marrow biopsy is more useful for staging of advanced disease.
  • Lymph node biopsy would be more likely to be positive, Reed-Sternberg cell is evident on microscopy
46
Q

Staging of Hodgkin’s Lymphoma?

A

Ann-Arbor

  • I: single lymph node
  • II: 2 or more lymph nodes/regions on same side of diaphragm
  • III: nodes on both sides of diaphragm
  • IV: spread beyond lymph nodes

Each stage may be subdivided into A or B

  • A = no systemic symptoms other than pruritus
  • B = weight loss > 10% in last 6 months, fever > 38c, night sweats (poor prognosis)
47
Q

Poor prognostic factors in Hodgkin’s lymphoma?

A
  • Age = 45 years
  • Stage IV disease
  • Hemoglobin < 10.5 g/dl
  • Lymphocyte count < 600/μl or < 8%
  • Male
  • Albumin < 40 g/l
  • White blood count = 15,000/μl
48
Q

Management of Hodgkin’s Lymphoma?

A

IA/IIA

  • Radiation therapy AND chemotherapy.
  • The choice of treatment depends on the age, sex, bulk and the histological subtype of the disease.

III, IVA or IVB

  • Combination chemotherapy alone

Large mass in the chest (regardless of stage)

  • Treated with combined chemotherapy and radiation therap.
  • Chemo includes: Doxorubicin, Bleomycin, Vincristine, Cyclophosphamide and other cytotoxic drugs.
49
Q

Hodgkin’s lymphoma types?

A
50
Q

Non-Hodgkin’s Lymphomas?

A
  • Diverse group of lymphomas that include any kind of lymphoma except Hodgkin’s lymphomas
  • Low-grade lymphoma is predominantly a disease of older people.
  • Most non-Hodgkin’s lymphomas are of B cell phenotype, though T cell tumours are recognised

Presentation

  • Most present with advanced disease, bone marrow infiltration being almost invariable.
  • Extra-nodal presentation is more common than Hodgkin’s disease.
  • Renal impairment in non-Hodgkin’s lymphomas usually occurs as a consequence of ureteric obstruction secondary to intra-abdominal or pelvic lymph node enlargement.
  • Anaemia, an elevated white cell count and/or thrombocytopaenia are suggestive of bone marrow infiltration.
51
Q

Management of NHL?

A
  • Lymph node biopsy is sufficient for a definitive diagnosis –> immuno-phenotyping and cytogenetic/molecular analysis.
  • High-grade lymphomas are responsive to chemotherapy and potentially curable,
  • Low-grade lymphomas are incurable with conventional therapy.
  • Chemotherapy is the mainstay of treatment in most cases
52
Q

Burkitt’s Lymphoma?

A

High grade B cell neoplasm (NHL)

Two forms

  • Endemic (African) form: typically involves maxilla or mandible
  • Sporadic form: abdominal (ileo-caecal) tumors are the most common form. More common in patients with HIV

Associated with the c-myc gene translocation, usually t(8:14)

EBV strongly implicated in African form but not so much sporadic

Common cause of Tumour Lysis Syndrome

53
Q

Tumour Lysis Syndrome?

A

Occurs after the initiation of a chemotherapeutic. TLS tends to occur in patients with bulky, rapidly proliferating, treatment-responsive tumors

Associations

  • Acute leukemia
  • High-grade non-Hodgkin’s lymphomas.
  • Pre-treatment raised LDH (levels of LDH correspond with tumor bulk)

Manifestation (rapid 48-72 hours after initiation)

  • Hyperkalaemia
  • Hyperuricaemia
  • Hyperphosphataemia
  • Hypocalcaemia
  • Acute renal failure

Management

  • Prevention is with good hydration before starting chemotherapy.
  • Hyperuricemia –> urine alkalinisation and allopurinol
  • Osmotic diuretics are NOT first line therapy and may contribute to the precipitation of uric acid in the renal tubules.
  • Dietary modifications include restricting dietary potassium.
  • Further chemotherapy should be withheld until the patient has fully recovered
54
Q

Haem malignancies genetics?

A
55
Q

Infections related to haem malignancies?

A

Viruses

  • EBV: Hodgkin’s and Burkitt’s lymphoma, nasopharyngeal carcinoma
  • HTLV-1 (Human T-lymphotropic virus Type I): Adult T-cell leukemia/lymphoma
  • HIV-1: High-grade B-cell lymphoma

Bacteria

  • Helicobacter pylori: gastric lymphoma (MALT)

Protozoa

  • Malaria: Burkitt’s lymphoma
56
Q

Stem cell transplants?

A
  • Not used in first complete remission in most haematological malignancies - reserved for first relapse/second complete remission (high treatment related morbidity/mortality)
  • Transplants from matched sibling donors are used as first line therapy in certain circumstances, including CML
  • If no siblings, then imatinib to induce remission is first choice
  • Blood Products
    • Irradiated blood - patients receiving a bone marrow transplant, patients with previous purine analogue exposure and a diagnosis of Hodgkin’s disease
    • CMV-negative blood - atients who may need a bone marrow transplant in the future (CMV carriage increases transplant mortality
57
Q

Causes of eosinophilia?

A

NAACCP

  • Neoplasia
  • Addison’s
  • Allergy/Asthma
  • Collagen vascular diseases
  • Cholesterol emboli
  • Parasites
58
Q

Bleeding times with diseases?

A
59
Q

Acquired factor VIII deficiency

A

Results from the development of inhibitors against factor VIII. Occurs mainly in the elderly.

Associations

  • Malignancy
  • Psoriasis
  • Pemphigus
  • Drugs: cephalosporins, penicillins

Diagnosis

  • Bleeding tendencies
  • APTT: is prolonged (intrinsic pathway).
  • APTT doesn’t correct/will only correct slightly with the adding of normal plasma.
  • Bethesda titre can quantify the inhibitor. There is a 20% mortality rate from acquired factor VIII deficiency.

Treat with recominant factor VIIa or factor VIII bypassing agent (latter is prothrombotic –> MI/DIC)

60
Q

Clotting pathways - intrinsic/extrinsic, PT/aPTT?

A
61
Q

Haemophilias?

A

Haemophilia A

  • X-linked; factor VIII (most common - 90%)

Haemophilia B

  • X-linked; factor IX (more severe but less common)

Haemophilia C

  • Autosomal; factor XI - not completely recessive, some heterozygotes show increased bleeding tendencies.
62
Q

Acquired haemophilia?

A

Associated with anti-factor VIII IgG antibodies and is idiopathic in the majority of cases.

Associations

  • Autoimmune diseases: (Rheumatoid Arthritis or IBD)
  • Drugs such as phenytoin

Mx

  • Sometimes replacement of factor VIII is all that is needed
  • Immunosupression with corticosteroids +/- steroid sparing agents such as cyclosporine may be required.
63
Q

Von Willebrand’s disease?

A

Most common inherited bleeding disorder. Mostly AD inheritence. Behaves like a platelet disorder.

Types

  • Type 1 - partial reduction in vWF (80% of patients)
  • Type 2: abnormal form of vWF
  • Type 3: total lack of vWF (autosomal recessive) most severe

Ix

  • PFA-100 has >95% sensitivity to diagnose vWD
  • Prolonged bleeding time
  • Slightly prolonged APTT
  • Decreased factor VIII levels
  • Defective platelet aggregation with ristocetin

Mx

  • TXA for mild bleeding
  • Desmopressin raises levels of vWF by inducing release of vWF from Weibel Palade bodies in endothelial cells. Used as prohyplaxis prior to procedures.
  • Factor VIII concentrate
64
Q

Role of vWF?

A
  • Promotes platelet adhesion to damaged endothelium
  • Carrier molecule for factor VIII
65
Q

Causes for severe and moderate thrombocytopenia?

A

Severe

  • ITP
  • TT
  • DIC
  • Hematological malignancy

Moderate

  • Heparin induced thrombocytopenia (HIT)
  • Drug-induced (e.g. quinine, diuretics, sulphonamides, aspirin, thiazides)
  • Alcohol and Vitamin B12 deficiency
  • Liver disease
  • Hypersplenism
  • Viral infection (EBV, HIV, hepatitis)
  • Pregnancy
  • SLE/antiphospholipid syndrome
66
Q

Idiopathic thrombocytopenic purpura (ITP)?

A

Immune mediated reduction in the platelet count. Antibodies are directed against the glycoprotein IIb-IIIa or Ib complex.

  • Acute - mostly children - M=F. May follow infection/vaccination, self-limiting over 1-2 weeks.
  • Chronic - young/middle aged women, relapsing-remitting course.

Ix

  • Antiplatelet autoantibodies (usually IgG)
  • Bone marrow aspiration shows megakaryocytes in the marrow. This should be carried out prior to the commencement of steroids in order to rule out leukemia

Mx

  • Oral prednisolone (80% of patients respond)
  • Splenectomy if platelets < 30 after 3 months of steroid therapy
  • IV immunoglobulins
  • Immunosuppressive drugs e.g. Cyclophosphamide
67
Q

Evans’ syndrome?

A

ITP in association with autoimmune haemolytic anaemia

68
Q

Thrombotic thrombocytopenic purpura mechanism?

A

Neurological features, renal failure, pyrexia and thrombocytopenia point towards a
diagnosis of TTP - difference from HUS = neuro signs and purpura.

  • Abnormally large and sticky multimers of vWF cause platelets to clump within vessels
  • Autoantibody-mediated inhibition of the enzyme ADAMTS13, which normally cleaves the multimers into smaller units
  • Increased platelet adhesion –> thrombi –> decreased numbers of circulating platelets
  • Overlaps with hemolytic uraemic syndrome (HUS)
69
Q

TTP features, causes, management?

A

Features

  • Rare, typically adult females
  • Fever
  • Fluctuating neuro signs (microemboli)
  • Microangiopathic hemolytic anemia
  • Thrombocytopenia
  • Renal failure

Causes

  • Post-infection e.g. Urinary, gastrointestinal
  • Pregnancy
  • Drugs: cyclosporin, oral contraceptive pill, penicillin, clopidogrel, aciclovir
  • Tumors
  • SLE
  • HIV

Management

  • No antibiotics - may worsen outcome
  • Plasma exchange is the treatment of choice
  • Steroids, immunosuppressants
  • Vincristine
70
Q

Drug causes of pancytopenia?

A
  • Cytotoxics
  • Antibiotics: trimethoprim, chloramphenicol
  • Anti-rheumatoid: gold, penicillamine
  • Carbimazole*
  • Anti-epileptics: carbamazepine
  • Sulphonylureas: tolbutamide
71
Q

Heparin induced thrombocytopenia (HIT)?

A

Immune mediated (IgG) drug reaction. Usually takes about 5 days to manifest.

Presentation

  • Bleeding is rare, more strongly associated with thrombosis (antibodies initiate platelet activation –> clots)
  • Both venous and arterial thrombosis

Dx (clinical)

  • Thrombocytopenia: PLT < 100 or <50% from the patient’s baseline
  • The exclusion of other causes of thrombocytopenia
  • The resolution of thrombocytopenia after cessation of heparin
  • HIT antibodies can be demonstrated using lab tests and assays (HIPA, SRA)

Management

  • Stop all forms of Heparin
  • Start alternative anticoagulant which do not cross-react with HIT antibodies, such as: Danaparoid, Lepirudin, Argatroban.
  • Oral anticoagulation with warfarin should NOT be initiated for longer-term protection from further events until substantial platelet count recovery has occurred
    • HIT patients who are switched to warfarin alone after the discontinuation of heparin may paradoxically have worsening thrombosis and develop venous limb gangrene and skin necrosis
72
Q

Hyposplenism blood film? e.g. post-splenectomy

A
  • Target cells
  • Howell-Jolly bodies
  • Cabot’s rings
  • Siderotic granules
  • Acanthocytes
  • Schizocytes
73
Q

Iron deficiency anaemia blood film?

A
  • Target cells
  • ‘Pencil’ poikilocytes
  • If combined with B12/folate deficiency a ‘dimorphic’ film
  • occurs with mixed microcytic and macrocytic cells
74
Q

Typical blood films for: G6PD deficiency, Myelofibrosis, Intravascular haemolysis, Megaloblastic anaemia?

A
  • G6PD = Heinz bodies
  • Myelofibrosis = ‘Tear drop’ poikilocytes
  • Intravascular Haemolysis = Schistocytes
  • Megaloblastic anaemia = Hypersegmented neutrophils
75
Q

Haem cancers blood films

A
76
Q

Stains and reagents used in haematology?

A
77
Q

Hereditary haemorrhagic telangectasia?

A

AD inheritence

Types

  • HHT1: chromosome 9, associated with AVM (cerebral and pulmonary)
  • HHT2: chromosome 12.

Features

  • Epistaxis
  • Telangiectasia develop on skin, mucous membranes and internal organs
  • Associated with pulmonary and other AV malformations in 10%
  • May present as iron-deficiency anemia secondary to bleeding in the GI tract or nasal mucosa
78
Q

Waldenstrom’s Macroglobulinemia?

A
  • Older men
  • Lymphoplasmacytoid malignancy characterized by the secretion of a monoclonal IgM paraprotein

Features

  • Monoclonal IgM paraproteinemia
  • Systemic upset: weight loss, lethargy
  • Hyperviscosity syndrome e.g. Visual disturbance
  • Hepatosplenomegaly
  • Lymphadenopathy
  • Cryoglobulinemia e.g. Raynaud’s
  • Raised ESR

Mx

  • Monoclonal antibody rituximab, sometimes in combination with
    chemotherapeutic drugs such as chlorambucil, cyclophosphamide, or Vincristine or with thalidomide.
  • Steroids
  • Plasmaphoresis can be used to address the hyperviscosity
79
Q

Differences between MGUS and myeloma?

A
  • Normal immune function
  • Normal beta-2 microglobulin levels
  • Lower level of paraproteinemia than myeloma (e.g. < 30g/l IgG, or < 20g/l IgA)
  • Stable level of paraproteinemia
  • No clinical features of myeloma (e.g. Lytic lesions on x-rays or renal disease)
80
Q

Features and diagnostic criteria for MGUS?

A

Features

  • Usually asymptomatic
  • No bone pain or increased risk of infections
  • Around 10-30% of patients have a demyelinating neuropath
  • M protein level < 30gm/l
  • No end-organ damage.

Diagnostic Criteria

  • Serum paraprotein <30 g/L AND
  • Clonal plasma cells <10% on bone marrow biopsy AND
  • NO myeloma-related organ or tissue impairment
81
Q

Methaemoglobulinaemia?

A

Oxidation of Fe2+ to Fe3+ by NADH methemoglobin reductase

Results in tissue hypoxia as Fe3+ cannot bind oxygen –> dissociation curve moved to the left

Causes

  • Congenital - Hb chain variants (HbM, HbH), deficiency of the enzyme
  • Acquired - drugs (sulphonamides, nitrates, dapsone, sodium nitroprusside, primaquine), chemicals (alanine dyes)

Features

  • ‘Chocolate’ cyanosis
  • Dyspnoea, anxiety, headache
  • Severe - acidosis, arrhythmias, seizures, coma
  • Normal PO2 but decreased sats

Management

  • Ascorbic acid if enzyme deficiency
  • IV methylene blue
82
Q

Fanconi’s anaemia?

A
  • Autosomal recessive
  • Aplastic anemia
  • Increased risk of AML
  • Neurological manifestation
  • Skeletal abnormalities
  • Skin pigmentation (café-au-lait spots)
83
Q

Haemochromatosis?

A

Autossomal Recessive - HFE gene, chromosome 6

Typical Tests

  • Transferrin saturation > 55% in men or > 50% in women
  • Raised ferritin (e.g. > 500 ug/l) and iron
  • Low TIBC

Diagnostic Tests

  • Molecular genetic testing for the C282Y and H63D mutations
  • Liver biopsy: Perl’s stain

Monitoring Venesection

  • ‘transferrin saturation should be kept below 50% and the serum ferritin
    concentration below 50 ug/l’
84
Q

Presentation and complications of haemochromatosis?

A

Presentation

  • Early symptoms include fatigue, erectile dysfunction and arthralgia (often of the hands)
  • ‘Bronze’ skin pigmentation
  • Diabetes Mellitus
  • Liver: stigmata of chronic liver disease, hepatomegaly, cirrhosis, hepatocellular deposition.
  • Cardiac failure (2nd to dilated cardiomyopathy)
  • Hypogonadism (2nd to cirrhosis and pituitary dysfunction - hypogonadotrophic hypogonadism)
  • Arthritis (especially of the hands) - joint X rays show chondrocalcinosis

Complications

  • Reversible - cardiomyopathy, skin pigmentation
  • Irreversible - cirrhosis, DM, hypogonadism, arthropathy
85
Q
A